{"result":[{"lastName":"Sibley","clinicalFocus":[{"focus":"Anatomic Pathology"},{"focus":"Pathology"}],"appointments":[{"appointment":"Professor,Pathology"}],"primaryAppointment":"Professor,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4113&type=small&showNoImage","displayName":"Richard Sibley","firstName":"Richard","href":"http://med.stanford.edu/profiles/Richard_Sibley","researchInterest":"Immunologic mechanism of rejection in humans and animal, models of organ transplantation; histological definition of clinical pathology studies of various renal disorders."},{"lastName":"Myers","clinicalFocus":[],"appointments":[{"appointment":"Emeritus Faculty, Acad Council,Medicine - Nephrology"}],"primaryAppointment":"Emeritus Faculty, Acad Council,Medicine - Nephrology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4332&type=small&showNoImage","displayName":"Bryan Myers","firstName":"Bryan","href":"http://med.stanford.edu/profiles/Bryan_Myers","researchInterest":"A novel approach is used to evaluate glomerular disease in humans, and its progression.  A combination of physiologic techniques, a morphometric analysis of glomeruli obtained by biopsy, and mathematical modeling of glomerular ultrafiltration is used to quantify the extent of glomerular injury in humans for the first time."},{"lastName":"Busque","clinicalFocus":[{"focus":"General Surgery"},{"focus":"Kidney and Pancreas Transplantation"},{"focus":"Liver Transplantation"}],"appointments":[{"appointment":"Professor - Med Center Line,Surgery - Multi-Organ Transplantation"}],"primaryAppointment":"Professor - Med Center Line,Surgery - Multi-Organ Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3809&type=small&showNoImage","displayName":"Stephan Busque","firstName":"Stephan","href":"http://med.stanford.edu/profiles/Stephan_Busque","researchInterest":"My research interest is focused on the improvement of clinical immunosuppression. I am  involved  in the evaluation of new immunosuppressive drugs, potentially more efficacious or less toxic.  My ultimate goal is to achieve tolerance, a state that would obviate the need for any drugs. I am an investigator part of a multidisciplinary tolerance induction project using total lymphoid irradiation and donor hematopoietic stem cells infusion after living donor kidney transplantation."},{"lastName":"Tan","clinicalFocus":[{"focus":"Kidney and Pancreas Transplantation"},{"focus":"Nephrology"},{"focus":"Nephrology (Kidney)"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Nephrology"},{"appointment":"MS, Dean's Office"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Nephrology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3846&type=small&showNoImage","displayName":"Jane C. Tan","firstName":"Jane","href":"http://med.stanford.edu/profiles/Jane_Tan","researchInterest":"My research relates to issues pertaining to clinical kidney transplantation. We have ongoing studies on the following topics.\r\n1. Renal senescence and kidney transplant, and chronic allograft nephropathy.\r\n2. Living donor safety and response to uninephrectomy.\r\n3. Biomarkers for post-transplant monitoring."},{"lastName":"Kambham","clinicalFocus":[{"focus":"Pathology and Laboratory Medicine"},{"focus":"Renal Pathology"},{"focus":"Anatomic Pathology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Pathology"}],"primaryAppointment":"Associate Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3829&type=small&showNoImage","displayName":"Neeraja Kambham","firstName":"Neeraja","href":"http://med.stanford.edu/profiles/Neeraja_Kambham","researchInterest":"Research interests primarily involve medical diseases of the native and transplant kidney. Other interests include liver transplantation pathology and gastrointestinal pathology."},{"lastName":"Alexander","clinicalFocus":[{"focus":"Nephrology (Kidney), Pediatric"},{"focus":"Pediatric Nephrology"},{"focus":"Dialysis"},{"focus":"Kidney Transplantation"},{"focus":"Continuous Renal Replacement Therapies"},{"focus":"Hypertension"},{"focus":"Acute and Chronic Kidney Failure"}],"appointments":[{"appointment":"Professor - Med Center Line,Pediatrics - Nephrology"},{"appointment":"Member,Child Health Research Institute"}],"primaryAppointment":"Professor - Med Center Line,Pediatrics - Nephrology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=5949&type=small&showNoImage","displayName":"Steven R. Alexander, MD","firstName":"Steven","href":"http://med.stanford.edu/profiles/Steven_Alexander","researchInterest":"Dialysis, kidney transplantation, continuous renal replacement therapy in pediatric patients; chronic kidney disease in pediatric patients."},{"lastName":"Melcher","clinicalFocus":[{"focus":"General Surgery"},{"focus":"Liver Transplantation"},{"focus":"Kidney Transplantation"},{"focus":"Hepatobiliary"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Surgery - Multi-Organ Transplantation"}],"primaryAppointment":"Assistant Professor - Med Center Line,Surgery - Multi-Organ Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=7640&type=small&showNoImage","displayName":"Marc L. Melcher","firstName":"Marc","href":"http://med.stanford.edu/profiles/Marc_Melcher","researchInterest":"My goal is to extend the benefits of organ transplant to greater numbers of patients while maintaining Stanford's excellent outcomes.  We have set up a protocol to treat morbidly obese patients, who normally would not qualify for kidney transplant, with bariatric surgery prior to kidney transplantation.  We are also developing the \"paired-organ exchange\" program at Stanford to increase the chances that patients with willing but incompatible living donors can still receive a living donor kidney."},{"lastName":"Li","clinicalFocus":[],"appointments":[{"appointment":"Software Developer,Pediatrics - Systems Medicine"},{"appointment":"Software Developer, Research,Pediatrics - Systems Medicine"}],"primaryAppointment":"Software Developer,Pediatrics - Systems Medicine","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=27445&type=small&showNoImage","displayName":"Li Li","firstName":"Li","href":"http://med.stanford.edu/profiles/Li_Li","researchInterest":""},{"lastName":"Grimm","clinicalFocus":[{"focus":"Pediatric Nephrology"}],"appointments":[{"appointment":"Professor - Med Center Line,Pediatrics - Nephrology"},{"appointment":"Member,Child Health Research Institute"}],"primaryAppointment":"Professor - Med Center Line,Pediatrics - Nephrology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=7989&type=small&showNoImage","displayName":"Paul C. Grimm","firstName":"Paul","href":"http://med.stanford.edu/profiles/Paul_Grimm","researchInterest":"Computerized image analysis of kidney and liver biopsies to quantitate and diagnose subtle changes in tissue structure. \r\nRenal Inflammation\r\nRenal Allograft Rejection\r\nRenal Fibrosis in; \r\n-Primary Kidney Disease\r\n-Transplant Kidney Disease\r\nLiver fibrosis\r\nSteatohepatitis"},{"lastName":"Meyer","clinicalFocus":[],"appointments":[{"appointment":"Professor,Medicine - Nephrology"}],"primaryAppointment":"Professor,Medicine - Nephrology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4497&type=small&showNoImage","displayName":"Timothy Meyer","firstName":"Timothy","href":"http://med.stanford.edu/profiles/Timothy_Meyer","researchInterest":"Inadequate removal of uremic solutes contributes to widespread illness in the more than 350,000 Americans maintained on hemodialysis.   But we know remarkably little about these solutes.  Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal  could be increased.  We should be able to improve treatment if we knew more about what we are trying to remove."},{"lastName":"Rabkin","clinicalFocus":[],"appointments":[{"appointment":"Emeritus Faculty, Acad Council,Medicine - Nephrology"}],"primaryAppointment":"Emeritus Faculty, Acad Council,Medicine - Nephrology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6052&type=small&showNoImage","displayName":"Ralph Rabkin","firstName":"Ralph","href":"http://med.stanford.edu/profiles/Ralph_Rabkin","researchInterest":"Dr Rabkin is examining the mechanism of the acquired resistance to hormones that develops in kidney failure.In particular he is studying the impact of kidney failure on the action of growth hormone and the role of impaired signal transduction as a cause of growth hormone resistance. He is also engaged in the study of growth factors in diabetic kidney disease."},{"lastName":"Lowsky","clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Blood & Marrow Transplantation"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Blood & Marrow Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3811&type=small&showNoImage","displayName":"Robert Lowsky","firstName":"Robert","href":"http://med.stanford.edu/profiles/Robert_Lowsky","researchInterest":"Dr. Lowsky's research is focused on understanding the role of regulatory T cells in the prevention of GVHD and in promoting immune tolerance following organ transplantation."},{"lastName":"Winkelmayer","clinicalFocus":[{"focus":"Nephrology"}],"appointments":[{"appointment":"Associate Professor,Medicine - Nephrology"},{"appointment":"Associate Professor (By courtesy),Health Research & Policy"}],"primaryAppointment":"Associate Professor,Medicine - Nephrology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=15938&type=small&showNoImage","displayName":"Wolfgang C. Winkelmayer, MD, ScD","firstName":"Wolfgang","href":"http://med.stanford.edu/profiles/Wolfgang_Winkelmayer","researchInterest":"I study the comparative effectiveness and safety of competing clinical strategies in patients with kidney disease, diabetes, or cardiovascular disease. Such strategies may include medications, devices, clinical tests, policies, or other approaches to providing or organizing clinical care. My research is based on large insurance databases, disease registries, clinical databases or electronic medical records. My explicit career goal is to improve care and outcomes of patients with these diseases."},{"lastName":"So","clinicalFocus":[{"focus":"Liver Cancer"},{"focus":"Liver Cancer - Surgery"},{"focus":"Gastrointestinal Cancers - Surgical Oncology"},{"focus":"General Surgery"}],"appointments":[{"appointment":"Professor - Med Center Line,Surgery - General Surgery"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4206&type=small&showNoImage","displayName":"Samuel So","firstName":"Samuel","href":"http://med.stanford.edu/profiles/Samuel_So","researchInterest":"Through a 3 pronged comprehensive program: translational and clinical research, early detection and  treatment, and promoting education, awareness and immunization, we are working towards the development of new strategies that will lead to the elimination of hepatitis B worldwide and reduce the threat and incidence of liver cancer. Our current research efforts focus on evaluating potential new diagnostic and treatment markers and novel targeted therapy for primary liver cancer."},{"lastName":"Perlroth","clinicalFocus":[],"appointments":[{"appointment":"Emeritus Faculty, Acad Council,Medicine - Cardiovascular Medicine"}],"primaryAppointment":"Emeritus Faculty, Acad Council,Medicine - Cardiovascular Medicine","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4181&type=small&showNoImage","displayName":"Mark Perlroth, MD","firstName":"Mark","href":"http://med.stanford.edu/profiles/Mark_Perlroth","researchInterest":"1. Adult Congenital Heart Disease \r\n2. Cardiac Transplantation\r\n3. General Cardiology\r\n4. Porphyrias"},{"lastName":"Lafayette","clinicalFocus":[{"focus":"Nephrology (Kidney)"},{"focus":"Glomerular Disease"},{"focus":"Amyloidosis"},{"focus":"Kidney and Pancreas Transplantation"},{"focus":"Nephrology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Nephrology"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Nephrology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4023&type=small&showNoImage","displayName":"Richard Lafayette","firstName":"Richard","href":"http://med.stanford.edu/profiles/Richard_Lafayette","researchInterest":"Initiating a glomerulonephritis cohort study, including immunologic characterization.  Interventional studies of preeclampsia exploring the nitric oxide, endothelin system and effects on glomerular function and morphometry.  Outcome studies in dialysis and acute renal failure patients.  Interventional and observational studies of glomerular disease, particularly IgA nephropathy."},{"lastName":"Kim","clinicalFocus":[],"appointments":[{"appointment":"Instructor,Psychiatry & Behavioral Science"}],"primaryAppointment":"Instructor,Psychiatry & Behavioral Science","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=14525&type=small&showNoImage","displayName":"Jane P. Kim","firstName":"Jane","href":"http://med.stanford.edu/profiles/Jane_Kim","researchInterest":"I am interested in the application of statistical methods to advance the understanding of mental illnesses.  I have a background in statistics, with specific training in survival analysis and a growing interest in clinical trials. My areas of expertise are the robustness of regression-based inference in randomized or non-randomized studies, methods for analyzing survival data subject to non-standard sampling schemes, and spatial statistics."},{"lastName":"Valantine","clinicalFocus":[{"focus":"Cardiology (Heart)"},{"focus":"Cardiovascular Medicine"},{"focus":"Heart and Lung Transplantation"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Cardiovascular Medicine"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Cardiovascular Medicine","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4322&type=small&showNoImage","displayName":"Hannah Valantine","firstName":"Hannah","href":"http://med.stanford.edu/profiles/Hannah_Valantine","researchInterest":"My lab is focused on understanding the mechanism mediating acute and chronic allograft failure, in particular on the role of microvascular injury in acute allograft failure and the mechanisms of mediating transplant coronary artery disease. 1. Role of microvascular injury in acute allograft failure."},{"lastName":"Johnston","clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"},{"focus":"Graft-Versus-Host Disease"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Blood & Marrow Transplantation"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Blood & Marrow Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4572&type=small&showNoImage","displayName":"Laura Johnston","firstName":"Laura","href":"http://med.stanford.edu/profiles/Laura_Johnston","researchInterest":"Clinical research in allogeneic and autologous hematopoietic cell transplantation (HCT), more specifically, allogeneic transplantation and graft versus host disease. Exploring methods of improving prevention and treatment of GVHD as well as the long term follow-up and/or quality of life of affected patients."},{"lastName":"Strober","clinicalFocus":[{"focus":"Immunology and Rheumatology"},{"focus":"Rheumatology"}],"appointments":[{"appointment":"Professor,Medicine - Immunology & Rheumatology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Medicine - Immunology & Rheumatology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4152&type=small&showNoImage","displayName":"Samuel Strober","firstName":"Samuel","href":"http://med.stanford.edu/profiles/Samuel_Strober","researchInterest":"Mechanisms of immune tolerance; regulatory processes in autoimmunity and transplantation and extrathymic T cell maturation."},{"lastName":"Jamison","clinicalFocus":[],"appointments":[{"appointment":"Professor Emeritus,Medicine - Nephrology"},{"appointment":"Emeritus Faculty, Acad Council,Medicine - Nephrology"},{"appointment":"Academic Secretary,Academic Secretary's Office"}],"primaryAppointment":"Professor Emeritus,Medicine - Nephrology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4541&type=small&showNoImage","displayName":"Rex L. Jamison","firstName":"Rex","href":"http://med.stanford.edu/profiles/Rex_Jamison","researchInterest":"Patients with advanced chronic kidney disease and end stage kidney disease have high rates of cardiovascular mortality and morbidity.  The purpose of the Homocysteine Study was to determine if lowering their high plasma homocysteine levels would reduce their mortality.  Secondary endpoints included reductions in myocardial infarction, stroke, and amputation of a lower extremity.  The results showed there was no improvement in survival or reduction in the cardiovascular events."},{"lastName":"Arai","clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Blood & Marrow Transplantation"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Blood & Marrow Transplantation","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6161&type=small&showNoImage","displayName":"Sally Arai","firstName":"Sally","href":"http://med.stanford.edu/profiles/Sally_Arai","researchInterest":"Research interest in utilizing post-transplant adoptive cellular immunotherapy to reduce GVHD and relapse in patients with high risk hematologic malignancies."},{"lastName":"Cohen","clinicalFocus":[{"focus":"Hematology, Pediatric"},{"focus":"Hematology/Oncology/Stem Cell Transplant,  Pediatric"},{"focus":"Oncology (Cancer), Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"appointments":[{"appointment":"Professor,Pediatrics"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Professor,Pediatrics","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3801&type=small&showNoImage","displayName":"Harvey Cohen","firstName":"Harvey","href":"http://med.stanford.edu/profiles/Harvey_Cohen","researchInterest":"My research interests extend from hypothesis-driven studies in biochemistry and cell biology to discovery-driven interests in proteomics and systems biology to clinical treatment of acute lymphoblastic leukemia of children, and pediatric palliative care."},{"lastName":"Zenios","clinicalFocus":[],"appointments":[{"appointment":"Professor,Faculty - GSB Faculty"},{"appointment":"Professor (By courtesy),Bioengineering"}],"primaryAppointment":"Professor,Faculty - GSB Faculty","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=12871&type=small&showNoImage","displayName":"Stefanos Zenios","firstName":"Stefanos","href":"http://med.stanford.edu/profiles/Stefanos_Zenios","researchInterest":""}]}